176 related articles for article (PubMed ID: 18309017)
1. Adjunctive intrapleural tissue plasminogen activator administered via chest tubes placed with imaging guidance: effectiveness and risk for hemorrhage.
Gervais DA; Levis DA; Hahn PF; Uppot RN; Arellano RS; Mueller PR
Radiology; 2008 Mar; 246(3):956-63. PubMed ID: 18309017
[TBL] [Abstract][Full Text] [Related]
2. Complex abdominal and pelvic abscesses: efficacy of adjunctive tissue-type plasminogen activator for drainage.
Beland MD; Gervais DA; Levis DA; Hahn PF; Arellano RS; Mueller PR
Radiology; 2008 May; 247(2):567-73. PubMed ID: 18372451
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Tissue Plasminogen Activator and DNase for Complicated Pleural Effusions Secondary to Abdominal Pathology.
Majid A; Ochoa S; Chatterji S; Fernandez-Bussy S; Kheir F; Rivera E; Cheng G; Folch E
Ann Am Thorac Soc; 2017 Mar; 14(3):342-346. PubMed ID: 28079399
[TBL] [Abstract][Full Text] [Related]
4. Concurrent Intrapleural Instillation of Tissue Plasminogen Activator and DNase for Pleural Infection. A Single-Center Experience.
Majid A; Kheir F; Folch A; Fernandez-Bussy S; Chatterji S; Maskey A; Fashjian M; Cheng G; Ochoa S; Alape D; Folch E
Ann Am Thorac Soc; 2016 Sep; 13(9):1512-8. PubMed ID: 27333122
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of chest tube administration of tissue plasminogen activator to treat retained hemothorax.
Stiles PJ; Drake RM; Helmer SD; Bjordahl PM; Haan JM
Am J Surg; 2014 Jun; 207(6):960-3. PubMed ID: 24495319
[TBL] [Abstract][Full Text] [Related]
6. Dose De-escalation of Intrapleural Tissue Plasminogen Activator Therapy for Pleural Infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project.
Popowicz N; Bintcliffe O; De Fonseka D; Blyth KG; Smith NA; Piccolo F; Martin G; Wong D; Edey A; Maskell N; Lee YCG
Ann Am Thorac Soc; 2017 Jun; 14(6):929-936. PubMed ID: 28324671
[TBL] [Abstract][Full Text] [Related]
7. Intrapleural Fibrinolytics and Deoxyribonuclease for Treatment of Indwelling Pleural Catheter-Related Pleural Infection: A Multi-Center Observational Study.
Fitzgerald DB; Muruganandan S; Tsim S; Ip H; Asciak R; Walker S; Uribe Becerra JP; Majid A; Ahmed L; Rahman NM; Maskell NA; Blyth KG; Lee YCG
Respiration; 2021; 100(5):452-460. PubMed ID: 33784710
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial.
Livingston MH; Mahant S; Connolly B; MacLusky I; Laberge S; Giglia L; Yang C; Roberts A; Shawyer A; Brindle M; Parsons S; Stoian C; Walton JM; Thorpe KE; Chen Y; Zuo F; Mamdani M; Chan C; Loong D; Isaranuwatchai W; Ratjen F; Cohen E
JAMA Pediatr; 2020 Apr; 174(4):332-340. PubMed ID: 32011642
[TBL] [Abstract][Full Text] [Related]
9. Intrapleural fibrinolytics combined with image-guided chest tube drainage for pleural infection.
Levinson GM; Pennington DW
Mayo Clin Proc; 2007 Apr; 82(4):407-13. PubMed ID: 17418067
[TBL] [Abstract][Full Text] [Related]
10. Intrapleural r-tPA in association with low-molecular heparin may cause massive hemothorax resulting in hypovolemia.
Anevlavis S; Archontogeorgis K; Tzouvelekis A; Kouliatsis G; Pozova S; Bougioukas I; Bouros D; Froudarakis ME
Respiration; 2011; 81(6):513-6. PubMed ID: 21063075
[TBL] [Abstract][Full Text] [Related]
11. Intrapleural hemorrhage after administration of tPA: a case report and review of the literature.
Goralski JL; Bromberg PA; Haithcock B
Ther Adv Respir Dis; 2009 Dec; 3(6):295-300. PubMed ID: 19934281
[TBL] [Abstract][Full Text] [Related]
12. Cerebral venous congestion as indication for thrombolytic treatment.
Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of intrapleural tissue-type plasminogen activator in the treatment of loculated parapneumonic effusions.
Zuckerman DA; Reed MF; Howington JA; Moulton JS
J Vasc Interv Radiol; 2009 Aug; 20(8):1066-9. PubMed ID: 19560940
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and safety of tissue plasminogen activator in the management of complicated parapneumonic effusions.
Weinstein M; Restrepo R; Chait PG; Connolly B; Temple M; Macarthur C
Pediatrics; 2004 Mar; 113(3 Pt 1):e182-5. PubMed ID: 14993574
[TBL] [Abstract][Full Text] [Related]
15. Stratifying fibrinolytic dosing in pediatric parapneumonic effusion based on ultrasound grade correlation.
James CA; Braswell LE; Pezeshkmehr AH; Roberson PK; Parks JA; Moore MB
Pediatr Radiol; 2017 Jan; 47(1):89-95. PubMed ID: 27709281
[TBL] [Abstract][Full Text] [Related]
16. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery.
Piccolo F; Pitman N; Bhatnagar R; Popowicz N; Smith NA; Brockway B; Nickels R; Burke AJ; Wong CA; McCartney R; Choo-Kang B; Blyth KG; Maskell NA; Lee YC
Ann Am Thorac Soc; 2014 Nov; 11(9):1419-25. PubMed ID: 25296241
[TBL] [Abstract][Full Text] [Related]
17. Recombinant tissue plasminogen activator in the treatment of pleural infections in adults.
Froudarakis ME; Kouliatsis G; Steiropoulos P; Anevlavis S; Pataka A; Popidou M; Mikroulis D; Pneumatikos I; Bouros D
Respir Med; 2008 Dec; 102(12):1694-700. PubMed ID: 18824340
[TBL] [Abstract][Full Text] [Related]
18. Intrapleural Fibrinolytic Therapy in Patients With Nondraining Indwelling Pleural Catheters.
Vial MR; Ost DE; Eapen GA; Jimenez CA; Morice RC; O'Connell O; Grosu HB
J Bronchology Interv Pulmonol; 2016 Apr; 23(2):98-105. PubMed ID: 27058711
[TBL] [Abstract][Full Text] [Related]
19. Concurrent Versus Sequential Intrapleural Instillation of Tissue Plasminogen Activator and Deoxyribonuclease for Pleural Infection.
Kheir F; Cheng G; Rivera E; Folch A; Folch E; Fernandez-Bussy S; Keyes C; Parikh M; Channick C; Chee A; Majid A
J Bronchology Interv Pulmonol; 2018 Apr; 25(2):125-131. PubMed ID: 29346247
[TBL] [Abstract][Full Text] [Related]
20. Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial.
Livingston MH; Mahant S; Ratjen F; Connolly BL; Thorpe K; Mamdani M; Maclusky I; Laberge S; Giglia L; Walton JM; Yang CL; Roberts A; Shawyer AC; Brindle M; Parsons SJ; Stoian CA; Cohen E
Trials; 2017 Jun; 18(1):293. PubMed ID: 28646887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
